A detailed history of Northwest Investment Counselors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northwest Investment Counselors, LLC holds 3,024 shares of BMY stock, worth $174,424. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,024
Holding current value
$174,424
% of portfolio
0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$39.66 - $51.75 $119,931 - $156,492
3,024 New
3,024 $156,000
Q1 2024

Apr 12, 2024

BUY
$47.98 - $54.4 $143,700 - $162,928
2,995 New
2,995 $162,000
Q3 2023

Oct 12, 2023

BUY
$57.89 - $64.73 $405 - $453
7 Added 0.21%
3,380 $196,000
Q2 2023

Jul 11, 2023

SELL
$63.71 - $70.74 $12,168 - $13,511
-191 Reduced 5.36%
3,373 $215,000
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $85,225 - $96,665
1,297 Added 57.21%
3,564 $247,000
Q4 2022

Jan 18, 2023

BUY
$68.48 - $81.09 $27,118 - $32,111
396 Added 21.17%
2,267 $0
Q2 2022

Jul 26, 2022

SELL
$72.62 - $79.98 $580 - $639
-8 Reduced 0.43%
1,871 $144,000
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $1,414 - $1,695
23 Added 1.24%
1,879 $137,000
Q4 2021

Jan 26, 2022

BUY
$53.63 - $62.52 $99,537 - $116,037
1,856 New
1,856 $116,000
Q2 2021

Jul 22, 2021

SELL
$61.91 - $67.42 $128,710 - $140,166
-2,079 Closed
0 $0
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $123,367 - $138,752
2,079 New
2,079 $131,000
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $123,159 - $139,562
-2,133 Closed
0 $0
Q3 2020

Oct 21, 2020

BUY
$57.43 - $63.64 $122,498 - $135,744
2,133 New
2,133 $129,000
Q4 2019

Jan 27, 2020

SELL
$49.21 - $64.19 $90,251 - $117,724
-1,834 Closed
0 $0
Q3 2019

Oct 30, 2019

BUY
$42.77 - $50.71 $78,440 - $93,002
1,834 New
1,834 $93,000
Q4 2017

Feb 01, 2018

SELL
$59.94 - $65.35 $98,061 - $106,912
-1,636 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$55.23 - $63.74 $90,356 - $104,278
1,636
1,636 $104,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.